These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1412877)

  • 1. Comparative results of second kidney transplantation.
    Velidedeoğlu E; Tokyay R; Cuhadaroğlu S; Haberal M
    Transplant Proc; 1992 Oct; 24(5):1846-7. PubMed ID: 1412877
    [No Abstract]   [Full Text] [Related]  

  • 2. Five-year experience with a triple drug protocol in renal transplantation.
    Pallardó LM; Sánchez J; García J; Puig N; Sánchez P; Górriz JL; Cruz JM
    Transplant Proc; 1992 Feb; 24(1):56-7. PubMed ID: 1539342
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression.
    Pallardó LM; Sánchez P; Sánchez J; García J; Beneyto I; Orero E; Rochera A
    Transplant Proc; 1994 Oct; 26(5):2536-7. PubMed ID: 7940781
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of two protocols for living-related renal transplantation: donor-specific transfusion versus cyclosporine.
    Mazzali M; Alves Filho G; Alves MA; de Faria JB
    Transplant Proc; 1995 Apr; 27(2):1832-3. PubMed ID: 7725525
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerance induction in human kidney retransplantation: impact of repeated HLA mismatches in 156 second renal grafts.
    Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):319-21. PubMed ID: 8438317
    [No Abstract]   [Full Text] [Related]  

  • 6. Does suboptimal immunosuppression contribute to chronic rejection?
    Simić S; Djukanović L; Stojković D; Balgojević R; Sinthoić M; Lezaić V; Radivojević D
    Transplant Proc; 1995 Feb; 27(1):909-10. PubMed ID: 7879226
    [No Abstract]   [Full Text] [Related]  

  • 7. Compared results of random and HLA DR semi-identical transfusion protocols.
    Hauet T; Tron de Bouchony E; Touchard G; Bauwens M; Baron M; Yver L; Lemaire G; Alcalay D
    Transplant Proc; 1995 Aug; 27(4):2459-60. PubMed ID: 7652882
    [No Abstract]   [Full Text] [Related]  

  • 8. Donor specific transfusions: a five-year experience with alternative protocols.
    Norman DJ; Henell K; Fletcher L; Barry J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2252-4. PubMed ID: 3274504
    [No Abstract]   [Full Text] [Related]  

  • 9. Is the graft origin an important factor in the 'center effect' in kidney transplantation?
    Mouquet C; Bitker MO; Barrou B; Benalia H; Luciani J; Clergue F; Chatelain C; Viars P
    Transplant Proc; 1990 Apr; 22(2):380-1. PubMed ID: 2326924
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of HLA matching in renal graft allocation.
    Shapira Z; Shmueli D; Bar-Nathan N; Lustig S; Nakache R; Sharabani E; Gayer E; Yussim A
    Transplant Proc; 1993 Dec; 25(6):3254-5. PubMed ID: 8266532
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of simultaneous pancreas and kidney transplantation on renal graft survival.
    Ricart MJ; Bacqué MC; Esmatjes E; Oppenheimer F; Vilardell J; Campistol JM; Carretero P; Fernández-Cruz L
    Transplant Proc; 1995 Aug; 27(4):2237-8. PubMed ID: 7652788
    [No Abstract]   [Full Text] [Related]  

  • 12. Related donor kidney transplantation is the best form of treatment for uremia.
    Groth CG; Fehrman I; Ringdén O; Lundgren G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893
    [No Abstract]   [Full Text] [Related]  

  • 13. Is HLA matching worthwhile in pancreatic transplantation?
    Hopt UT; Büsing M; Schareck W; Pfeffer F; Irkin I; Becker HD
    Transplant Proc; 1992 Jun; 24(3):909-10. PubMed ID: 1604664
    [No Abstract]   [Full Text] [Related]  

  • 14. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival.
    Mizutani K; Katoh N; Yamada S; Ono Y; Takeuchi N; Matsuura O; Ohshima S
    Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797
    [No Abstract]   [Full Text] [Related]  

  • 15. An ABO incompatible sibling as rescue kidney donor.
    Blohmé I; Mjörnstedt L; Rydberg L; Nyberg G; Tufveson G
    Transplant Proc; 1994 Jun; 26(3):1745. PubMed ID: 8030115
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-therapy vs triple-therapy immunosuppression in cadaveric renal transplants.
    Carmellini M; Romagnoli J; Pietrabissa A; Di Stefano R; Oleggini M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1994 Oct; 26(5):2546-7. PubMed ID: 7940785
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal transplantation in patients with lymphocytotoxic antibodies--a 5-year experience from a single centre.
    Mjörnstedt L; Konar J; Nyberg G; Olausson M; Sandberg L; Karlberg I
    Transplant Proc; 1992 Feb; 24(1):333-4. PubMed ID: 1539300
    [No Abstract]   [Full Text] [Related]  

  • 18. Donor-specific transfusion for kidney transplantation in the cyclosporine era.
    Inoue S; Aikawa M; Dobashi Y; Kuzuhara K; Yanagisawa T; Ootubo O; Mimura N
    Transplant Proc; 1996 Jun; 28(3):1220-1. PubMed ID: 8658633
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of cyclosporine A on the outcome of one-haplotype identical kidney grafts from a living related donor.
    Papadimitriou M; Vakianis P; Malliara M; Economidou D; Alexopoulos E; Belechri AM; Koukoudis P; Papadopoulou D; Syrganis C; Polymenidis Z
    Transplant Proc; 1994 Oct; 26(5):2548-9. PubMed ID: 7940786
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignancies under cyclosporine after kidney transplantation: analysis of a 10-year period.
    Frei U; Bode U; Repp H; Schindler R; Brunkhorst R; Vogt P; Hauss J; Pichlmayr R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1394-6. PubMed ID: 8442152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.